Why the study?
Hypertension is the most common cardiovascular disease in Nigeria and contributes to a large non-communicable disease burden, prompting the need to evaluate a large-scale treatment and control program.
Does a multi-level hypertension control program improve hypertension treatment and control in primary healthcare centers in Nigeria?
Does a multi-level hypertension control program improve hypertension treatment and control in primary healthcare centers in Nigeria?
This paper describes the rationale and design of a large-scale implementation trial for a multi-level hypertension control program in Nigerian primary healthcare centers.
No takes yet. Share an insight, caveat, or question.
Protocol for large-scale hypertension trial in Nigerian primary care; leaves open efficacy on treatment and control until results emerge.
Baldridge et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: